ACP
ALBO

Acuta Capital Partners’s Albireo Pharma Inc ALBO Stock Holding History

Acuta Capital Partners’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-84,961
Closed -$1.12M – 72
2015
Q3 		$1.12M Sell
84,961
-11,263
-12% -$284K 0.65% 40
2015
Q2 		$2.97M Buy
+96,224
New +$3.23M 1.84% 20

Other funds holding ALBO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Acuta Capital Partners's ALBO Position: Q4 2015 in Review

Acuta Capital Partners sold out of Albireo Pharma Inc (ALBO) in Q4 2015, closing a stake of 84,961 shares — an estimated $1.12M sold.

Acuta Capital Partners first reported a position in ALBO in Q2 2015 and held it in 2 quarters. The position peaked at $2.97M in Q2 2015. 33 funds tracked by Wall St. Rank hold ALBO as of Q4 2015.

  • Acuta Capital Partners reported no remaining Albireo Pharma Inc position as of Q4 2015 after selling out during the quarter.
  • Acuta Capital Partners sold 84,961 Albireo Pharma Inc shares in Q4 2015, an estimated $1.12M.
  • Acuta Capital Partners first reported a position in Albireo Pharma Inc in Q2 2015 and held it in 2 quarters.
  • Acuta Capital Partners's Albireo Pharma Inc position peaked at $2.97M in Q2 2015.
  • 33 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2015.

Based on Acuta Capital Partners's 13F filing for Q4 2015, filed 12 Feb 2016.